RESUMEN
Background: The most acute manifestation of coronary artery disease is ST-segment elevation myocardial infarction (STEMI) and is associated with mortality and morbidity. In the majority of cases, complete thrombotic occlusion develops from an atherosclerotic plaque in an epicardial coronary vessel is the cause of STEMI. Early diagnosis and immediate reperfusion reduce the risk of post-STEMI complications and heart failure and thereby are the most effective ways to limit myocardial ischemia and infarct size. If primary percutaneous coronary intervention (PCI) cannot be performed within 120 minutes of STEMI diagnosis, fibrinolysis therapy should be administered to dissolve the occluding thrombus and PCI has become the preferred reperfusion strategy in patients with STEMI. Methods: From the emergency section of the hospital in the month of October 2021, 7 adult patients were identified with ST-segment–elevation myocardial infarction undergoing primary percutaneous coronary. We used the framework of regression discontinuity to test for discontinuity at 90 minutes among the included cases. The Door - Balloon as 90 minutes minus the time between hospital arrival and catheterization laboratory arrival -defined as a novel variable. To assess the relationship between remaining Door - Balloon time and access site we have estimated multivariable logistic regression models. Results: The results of primary PTCA in the month of October 2021 were performed in less than 90 minutes without any mortality in 7 patients. Conclusions: Our Data on mortality and morbidity benefits of primary angioplasty shows a 100% decrease in mortality of patients undergoing primary PTCA within 90 minutes as compared to international data which shows a 40% decrease.
RESUMEN
BACKGROUND AND OBJECTIVES: Many western studies have shown that primary percutaneous transluminal coronary angioplasty (PTCA) may have better clinical result over thrombolytic therapy in patients with acute myocardial infarction. There are, however, few reports about the role of primary PTCA in Korea. We reviewed the cases of primary PTCA and thrombolysis with delayed PTCA in Samsung Medical Center to compare the clinical outcomes of two treatment modalities. MATERIALS AND METHOD: This study was a non-randomized and retrospective trial. From August 1995 to March 1998, 80 AMI patients within 12 hours of symptom onset underwent primary PTCA (n=26) or thrombolytic therapy (n=54) in Samsung Medical Center. Patients who had thrombolysis were performed coronary angiography fourth to fifth hospital day routinely. Risk factors and time to treatment (pain-to-needle time and door- to-needle time) were reviewed from patient record. Angiographic data including TIMI flow were obtained from angiography data base and angiographic film. We compared the 30-day and 8-month event rate of death, re-infarction, re-PTCA, and CABG between two groups. RESULTS: Baseline characteristics (sex, age, blood pressure, heart rate, AMI location, ejection fraction of left ventricle) were similar between two groups. There was no statistically significant difference in pain-to-needle time and door-to-needle time between two groups. The 30-day mortality rate was similar between two groups (primary group 3.8%, thrombolysis 5.6%, p=1.0). The 30-day event rate also showed no difference between two groups (primary PTCA 7.7%, thrombolysis 11.1%, p=1.0) and there was similar tendency in 8-month event rate (primary PTCA 19.2%, thrombolysis 14.8%, p=0.62). However, the admission duration of primary PTCA group was shorter than that of thrombolysis (8.7 vs 12 days, p=0.03). CONCLUSION: Primary PTCA have similar clinical outcome except shorter hospital admission duration when compared to thrombolysis with routine elective coronary angiography and delayed PTCA in AMI patients without cardiogenic shock.